Summary
The action of AD6 was tested in vitro on human platelets by measuring beta-thromboglobulin (BTG), platelet factor 4 (PF4) and thromboxane B2 (TXB2) release as well as aggregation. BTG and PF4 release from blood anticoagulated with sodium citrate was inhibited by AD6 during a 3 h incubation. Platelet rich plasma (PRP) was stimulated with ADP, collagen, sodium arachidonate, PAF, A23187 and epinephrine, while resuspended washed platelets (WP) were stimulated by thrombin. AD6 (5–100 μM) inhibited dose dependently aggregation, BTG, PF4 and TXB2 release induced by threshold concentration of all the tested aggregating agents; however AD6 action could be overcome by increasing the concentration of the stimulating agents. After cyclo-oxygenase blockade by acetylsalicylic acid (ASA), PRP was stimulated by a supramaximal concentration of PAF. Under these circumstances we could observe a reversible aggregation and a partial release of BTG and PF4, AD6 was able to further reduce aggregation and release. Cyclic AMP accumulation induced in WP by prostacyclin was not modified by AD6 (100 μM), while theophylline greatly potentiated prostacyclin action. We conclude that AD6 is an inhibitor of platelet activation in vitro. Its mode of action is different from cyclo-oxygenase blockade and provides inhibition of platelet activation by a number of different stimuli.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Aporti F, Finesso M, Granata L (1978) Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxy coumarin (AD6) on the coronary circulation in the dog. Pharmacol Res Commun 10:469–477
Born GVR (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194:926–927
Cazenave JP, Packham MA, Mustard JF (1973) Adherence of platelets to a collagen coated surface; development of a quantitative method. J Lab Clin Med 82:978–988
Dejana E, de Castellarnau C, Balconi G, Rotilio D, Pietra A, de Gaetano G (1982) AD6, a coronary dilating agent, stimulates PGI2 production in rat aorta ex vivo and in human endothelial cells in culture. Pharmacol Res Commun 14:719–724
Di Minno G, Bertelé V, Bianchi L, Barbieri B, Cerletti C, Dejana E, de Gaetano G, Silver MJ (1981) Effects of an epoxymethano stable analogue of prostaglandin endoperoxides (U-46619) on human platelets. Thromb Haemostas 45:103–106
Galli C, Agradi E, Petroni A, Socini A (1980) Effects of 8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxy carbonyl methoxy coumarin (AD6) on aggregation, arachidonic acid metabolism and thromboxane B2 formation in human platelets. Pharmacol Res Commun 12:329–337
Ingerman-Wojenski C, Silver MJ, Smith JB, Macarak E (1981) Bovine endothelial cells in culture produce thromboxane as well as prostacyclin. J Clin Invest 67:1292–1296
Kinlough-Rathbone RL, Packham MA, Mustard JF (1983) Platelet aggregation. In: Harker LA, Zimmerman TS (eds) Methods in hematology. Measurement of platelet function. Churchill Livingstone, Edinburgh, pp 64–91
Lauri D, Cerletti C, de Gaetano G (1985) Amplification of primary response of human platelets to platelet activating factor: aspirin-sensitive and aspirin-insensitive pathways. J Lab Clin Med 105:653–658
Ludlan CA, Cash JD (1976) Studies on the liberation of β-thromboglobulin from human platelets in vitro. Br J Hematol 33:239–247
MacIntyre DE, Shaw AM (1983) Phospholipid-induced human platelet activation: effects of calcium channel blockers and calcium chelators. Thromb Res 31:833–844
Mattiasson I, Israelsson B, Stavenow L, Hodd B (1982) Effects of thrombin, acetyl salicylic acid and prostaglandins on spontaneous efflux of norepinephrine and beta-thromboglobulin from platelets in calcium/magnesium deficient environment. Thromb Res 28:765–772
Pengo V, Boschello M, Marzari A, De Santi C, Schivazappa L, Bruno R (1985) Farmacodinamica dell'AD6, un derivato cumarinico ad azione antipiastrinica. Le Basi Razionali della Terapia 15:83–84
Petroni A, Socini A, Blasevich M, Borghi A, Galli C (1985) Differential effects of various vasoactive drugs on basal and stimulated levels of TXB2 and 6-Keto-PGF1α in rat brain. Prostaglandins 29:579–587
Prosdocimi M, Finesso M, Tessari F, Gorio A, Languino LR, de Gaetano G, Dejana E (1985) Inhibition by AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxy coumarin) of platelet aggregation in dog stenosed coronary artery. Thromb Res 39:399–409
Prowse C, Pepper D, Dawes J (1982) Prevention of the platelet alpha-granule release reaction by membrane-active drugs. Thromb Res 25:219–227
Siess W, Frances L, Siegel FL, Lapetina EG (1983) Arachidonic acid stimulates the formation of 1,2-diacylglycerol and phosphatidic acid in human platelets (Degree of phospholipase C activation correlates with protein phosphorylation, platelet shape change, serotonin release, and aggregation). J Biol Chem 258:11236–11242
Socini A, Petroni A, Colli S, Colombo C, Galli C (1982) Effects of the coumarin derivative AD6 on platelet aggregation, platelet vessel wall interactions and 6 keto PGF1α production in perfused aortas, in experimentally hypercholesterolaemic rabbits. Pharmacol Res Commun 14:189–197
Weber G, Bianciardi G, Pierli C (1978) Preliminary observations on the ultrastructural modifications of the freeze-cleaved circulating platelets surface in hypercholesterolemic rabbits treated with AD6. Pharmacol Res Commun 10:739–746
Weber G, Bianciardi G, Toti P, Massari P, Orlando P (1985) Observations on the effects of some antiaggregating drugs on platelet specific protein discharge after a very weak stimulus. Pharmacol Res Commun 17:129–135
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Prosdocimi, M., Zatta, A., Gorio, A. et al. Action of AD6 (8-monochloro-3-beta-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxy coumarin) on human platelets in vitro. Naunyn-Schmiedeberg's Arch. Pharmacol. 332, 305–310 (1986). https://doi.org/10.1007/BF00504872
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00504872